Small effect sizes in these variables compared to CS were also evident for APD and ALS, though the comparisons did not reach statistical significance.
← all excerpts
Plasma NfL and GFAP in the preclinical stages of neurodegenerative diseases: insights from the UK Biobank.
1
—
—